Brief: Renovorx Announces Presentation At Symposium On Clinical Interventional Oncology (CIO) Highlighting Its Innovative Therapy Platform For Targeted Treatment Of Pancreatic Cancer
28/09/2022 14:01
Sept 28 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES PRESENTATION AT SYMPOSIUM ON CLINICAL
INTERVENTIONAL ONCOLOGY (CIO) HIGHLIGHTING ITS INNOVATIVE
THERAPY PLATFORM FOR TARGETED TREATMENT OF PANCREATIC CANCER
Source text for Eikon: ID:nBw6kZMw6a
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer